Sowa Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,218
Closed -$45K 178
2020
Q4
$45K Sell
1,218
-146
-11% -$5.36K 0.03% 138
2020
Q3
$47K Sell
1,364
-358
-21% -$12.6K 0.03% 128
2020
Q2
$53K Hold
1,722
0.04% 117
2020
Q1
$53K Hold
1,722
0.05% 106
2019
Q4
$64K Buy
+1,722
New +$61.3K 0.05% 109

Other funds holding PFE

Sowa Financial Group's PFE Position: Q1 2021 in Review

Sowa Financial Group sold out of Pfizer (PFE) in Q1 2021, closing a stake of 1,218 shares — an estimated $45K sold.

Sowa Financial Group first reported a position in PFE in Q4 2019 and held it in 5 quarters. The position peaked at $64K in Q4 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Sowa Financial Group reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
  • Sowa Financial Group sold 1,218 Pfizer shares in Q1 2021, an estimated $45K.
  • Sowa Financial Group first reported a position in Pfizer in Q4 2019 and held it in 5 quarters.
  • Sowa Financial Group's Pfizer position peaked at $64K in Q4 2019.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Sowa Financial Group's 13F filing for Q1 2021, filed 7 Apr 2021.